home / stock / iclr / iclr news


ICLR News and Press, ICON plc From 01/24/24

Stock Information

Company Name: ICON plc
Stock Symbol: ICLR
Market: NASDAQ
Website: iconplc.com

Menu

ICLR ICLR Quote ICLR Short ICLR News ICLR Articles ICLR Message Board
Get ICLR Alerts

News, Short Squeeze, Breakout and More Instantly...

ICLR - Biogen slips as UBS cuts to Neutral on Alzheimer's drug uptake

2024-01-24 08:54:54 ET More on Biogen, Eisai Co., Ltd., etc. Biogen Inc. (BIIB) JPMorgan 42nd Annual Healthcare Conference (Transcript) Biogen: LEQEMBI's $10 Billion Potential Biogen Inc. (BIIB) Evercore ISI 6th Annual HealthCONx Conference (Transcript) Eisai...

ICLR - New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment

ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent industry survey of over 100 professionals engaged in obesity-related clinical research to measure industry opinions on trends within this therapeuti...

ICLR - ClearBridge Mid Cap Strategy Q4 2023 Portfolio Manager Commentary

2024-01-22 13:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Mid cap stocks generat...

ICLR - ClearBridge Select Strategy Q4 2023 Portfolio Manager Commentary

2024-01-14 10:25:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...

ICLR - ICON Issues Financial Guidance for Full Year 2024

Highlights Full Year 2024 Revenue guidance in the range of $8,400 - $8,800 million, representing growth of 3.2% – 8.1% over Full Year 2023 Revenue guidance midpoint. Full Year 2024 adjusted earnings per share 1 guidance in the range of $14.50 - $15.30, representing growth o...

ICLR - Objective long/short (ICLR) Report

2024-01-09 00:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ICLR - Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

Survey points to importance of strategic engagement with investors and effective asset development strategies to optimise funding ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today launched its “Optimising biotech fundi...

ICLR - ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference

ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15pm PST/8.15pm EST. Any chan...

ICLR - Growth at a reasonable price stocks for 2024 - Jefferies

2023-12-19 12:08:34 ET More on iShares Russell 2000 ETF: Peter Lynch Says Forget Tech Stocks, The Bargains Are Here: IWM Vs. VB IWM: Santa Rally On Steroids (Rating Downgrade) The Week On Wall Street: Holiday Edition Money market funds attract more than $50B ...

ICLR - ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

Healthcare intelligence organisation earns recognition as employer of choice and leading innovator in the clinical trial industry ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half of 2023 with positiv...

Previous 10 Next 10